SARS-CoV-2 mRNA Vaccines Elicit Different Responses in Immunologically Naïve and Pre-Immune Humans

As the COVID-19 pandemic continues, the authorization of vaccines for emergency use has been crucial in slowing down the rate of infection and transmission of the SARS-CoV-2 virus that causes COVID-19. In order to investigate the longitudinal serological responses to SARS-CoV-2 natural infection and...

Descripción completa

Detalles Bibliográficos
Autores principales: Forgacs, David, Jang, Hyesun, Abreu, Rodrigo B., Hanley, Hannah B., Gattiker, Jasper L., Jefferson, Alexandria M., Ross, Ted M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8502960/
https://www.ncbi.nlm.nih.gov/pubmed/34646267
http://dx.doi.org/10.3389/fimmu.2021.728021

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8502960/
https://www.ncbi.nlm.nih.gov/pubmed/34646267
http://dx.doi.org/10.3389/fimmu.2021.728021

Ejemplares similares